Additional file 2: Table S2. of High rate of complete responses to immune checkpoint inhibitors in patients with relapsed or refractory Hodgkin lymphoma previously exposed to epigenetic therapy
Year: 2016
Type: article
Abstract: Treatment schedule of combined 5-azacitidine and romidepsin (phase 1 study, NCT01998035). (DOCX 57 kb)
Source: Figshare
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7136150131